Joint Formulary & PAD

Pancreatin - Pancreatic insufficiency

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Capsules
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
Nutrizym recommended in pregnancy / breastfeeding due to theoretical concern of phthalate content of Creon.
 

Status 2

Blue
Formulations :
  • Powder
Associated Icons :
Restrictions / Comments :
Important
SASH restrict to tube-fed patients only (Pancrex V powder)

PAD Profile

ChemicalSubstance :
Pancreatin
Indication :
Pancreatic insufficiency
Group Name :
Keywords :
Pancreatic enzyme deficiency, Pancreatic enzyme replacement therapy, PERT, pancreatin supplements
Brand Names Include :
Creon, Creon Micro, Pancrex V, Pancrex V Forte, Nutrizym 22,
Important Information :
Prescribe by brand - product with multiple ingredients. GP initiation following specialist recommendation.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Pancreatin is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Pancreatic insufficiency.

  • No records returned.

Committee Recommendations (2)

The Surrey Heartlands Integrated Care System Area Prescribing Committee noted the ongoing shortages of pancreatic enzyme replacement therapies.

Local guidance has been produced to summarise current issues and information and actions for prescribers, community pharmacies and patients.

The Surrey Heartlands Area Prescribing Committee noted the ongoing shortages of pancreatic enzyme replacement therapies.

Updated information can be found on the Pancreatic Society of Great Britain & Ireland webite: Position Statement: Pert Shortage | Pancreatic Society of Great Britain and Ireland (psgbi.org)